Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1991
06/18/1991US5024836 Stable lyophilized live herpes virus vaccine
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/16/1991WO1991008774A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2071872A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/15/1991CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/14/1991CA2071858A1 Hiv-1 env fragment fusion protein
06/14/1991CA2032079A1 Method for treating cardiac malfunction
06/13/1991WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
06/13/1991WO1991008226A1 Sperm antigen corresponding to a sperm autoantigenic epitope and methods of using the same
06/13/1991WO1991008224A1 Im peptides
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/13/1991WO1991007987A1 Chimeric antibody for detection and therapy of infectious and inflammatory lesions
06/13/1991WO1991002062A3 C-erbb-2 external domain: gp75
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0431679A1 Method of stabilizing recombinant hepatitis B virus surface proteins from yeast
06/12/1991EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
06/12/1991EP0431541A2 Toxoplasma gondii antigen, its production and use
06/12/1991EP0431327A1 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
06/12/1991EP0431156A1 Vaccine against bovine leukemia virus
06/12/1991EP0431128A1 Self-assembled, defective, non-self-propagating viral particles
06/12/1991EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
06/12/1991EP0431064A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus
06/12/1991EP0431045A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids
06/12/1991EP0431038A1 Production of bluetongue virus non-structural proteins using a baculovirus expression vector
06/12/1991EP0430999A1 Monoclonal antibody for inhibiting cell infection by hiv viruses
06/12/1991CN1052144A Compounds and methods for treatment and diagnosis of cancer
06/12/1991CN1052049A Process for preparing biologic resisting tumour
06/12/1991CA2031763A1 Process for purification of a 69000 dalton antigentic protein from bordetella pertussis
06/11/1991US5023077 Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
06/11/1991CA2005162A1 Method for antibody targeting of diagnostic or therapeutic agents
06/11/1991CA1284769C Intraoperative and endoscopic tumor detection and therapy
06/09/1991WO1991009311A1 Method for diagnosing neurodegenerative diseases
06/09/1991CA2070812A1 Method for diagnosing neurodegenerative diseases
06/09/1991CA2031468A1 Malaria vaccine
06/06/1991DE3940009A1 New mannose-specific lectin
06/06/1991DE3939470A1 Diagnosis and prevention of human parvovirus B19 infection - using synthetic penta- and higher peptide(s) and antibodies
06/05/1991WO1991007986A1 Method of treating septic shock
06/05/1991EP0430645A2 Vaccines
06/05/1991EP0430642A1 Methods of diagnosing and monitoring rheumatic diseases
06/05/1991EP0430517A2 Biomosaic polymers and method for preparing same
06/05/1991EP0430193A1 Monoclonal antibodies and their use
06/05/1991EP0430065A2 Barbiturate assay compositions and methods
06/05/1991EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component
06/05/1991EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity
06/05/1991EP0429484A1 Porcine polyclonal and monoclonal antibodies
06/05/1991EP0429470A1 Antibody recognition of fragments from cytomegalovirus
06/05/1991CN1012712B Hepatitis a virus purified and triply cloned
06/05/1991CA2070424A1 Method of treating septic shock
06/04/1991US5021560 Glycoprotein extract from proteolysis of molluscan hemocyanin
06/04/1991US5021349 Culture medium containing human albumin, process for the preparation of an injectable product from this medium, product obtained and its use, and composition obtained
06/04/1991US5021348 Attenuated hepatitis A virus
06/04/1991US5021347 DNA insert coding for a surface antigen
06/04/1991US5021342 Vaccines
06/02/1991WO1991008301A1 PROTEINS PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS
06/02/1991WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991CA2070166A1 Proteins inhibiting the interaction between an immunoglobin fc fragment and its receptor, and their therapeutical use, especially in the treatment of hiv related ailments
06/02/1991CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding
05/1991
05/30/1991WO1991008294A1 Novel vaccine
05/30/1991WO1991007979A1 Chimeric proteins
05/30/1991WO1991007509A1 Localization and characterization of the wilms's tumor gene
05/30/1991WO1991007483A2 Mammalian pancreatic cholesterol esterase
05/30/1991WO1991007439A1 Control of secretion of milk
05/30/1991WO1991007423A1 Dna binding proteins including androgen receptor
05/30/1991CA2069622A1 Vaccine
05/30/1991CA2069106A1 Chimeric proteins
05/30/1991CA2068533A1 Control of secretion of milk
05/30/1991CA2030175A1 Methods of diagnosing and monitoring rheumatic diseases
05/29/1991WO1991007985A1 Monoclonal antibody which distinguishes helper inducer and supressor inducer ce4+ lymphocytes
05/29/1991EP0429242A2 Specific binding agents
05/29/1991EP0428656A1 Human cell line lc5 and its use.
05/29/1991CN1051732A Method for isolating biologically active compounds
05/28/1991US5019557 Method for the effective treatment of disease conditions in humans associated with HTLV-III infection
05/28/1991US5019502 Process for removing bacterial endotoxin from gram-negative polysaccharides
05/28/1991US5019388 Inactivating cells with glutaraldehyde; complexing with L-lysine; dogs
05/28/1991US5019387 Production of antibodies to HIV
05/28/1991US5019386 Hepatitis B vaccine
05/28/1991US5019385 Novel lymphopine LK 2 and pharmaceutic compositions containing same
05/28/1991US5019384 Immunonodulating compositions and their use
05/28/1991US5019383 Synthetic Vaccines
05/28/1991CA1284507C Melphalan derivatives
05/23/1991DE3942728C1 New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
05/22/1991EP0428485A1 Novel antiidiotypic monoclonal antibodies
05/22/1991EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy
05/22/1991EP0427984A1 Articles for use in enzyme immuno-assay techniques, and methods of making and using such articles
05/22/1991EP0427850A1 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
05/22/1991EP0427768A1 Polypeptide pertussis toxin vaccine
05/22/1991EP0427715A1 Biocompatible, substance-specific reagents for treating physiological fluids
05/21/1991WO1991007425A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/21/1991US5017688 Peptides involved in the pathogenesis of HIV infection
05/21/1991US5017687 Polypeptides Immunologically Reactive With HTLV Antibodies
05/21/1991US5017487 Genetic engineering
05/21/1991CA2068713A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/18/1991WO1991007500A1 Specific binding agents
05/18/1991CA2066670A1 Specific binding agents
05/16/1991WO1991007419A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use
05/16/1991WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/16/1991WO1991006664A1 Method for synthesizing adenosine phosphate derivatives and derivatives thereby obtained
05/16/1991WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991WO1991006653A1 Recombinant vaccine for porcine pleuropneumonia
1 ... 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 ... 1823